Patient enrolment into HIV care and treatment within 90 days of HIV diagnosis in eight Rwandan health facilities: A review of facility-based registers

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Kayigamba, Felix R ^a   Bakker, Mirjam I ^b   Fikse, Hadassa ^b   Mugisha, Veronicah ^c   Asiimwe, Anita ^d   van der Loeff, Maarten F Schim ^e,f,g  

^a INTERACT   (Rwanda)

^b ROYAL TROPICAL INSTITUTE   (Netherlands)

^c Columbia University ^*  (United States)

^d RWANDA BIOMEDICAL CENTER   (Rwanda)

^e AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRENATAL CARE; PRESCHOOL CHILD; RWANDA; SCHOOL CHILD; SEX DIFFERENCE; AMBULATORY CARE; HEALTH CARE DELIVERY; IMMUNOLOGY; MIDDLE AGED; PUBLIC HEALTH; TIME;

HARNESS;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH FACILITIES; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INFANT; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; RWANDA; TIME FACTORS; YOUNG ADULT;

EID: 84861014700     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036792     Document Type: Article

References (26)

1. World Health Organization (2006) HIV/AIDS Programme: Towards universal access by 2010. prevention HowWHOisworkingwithcountriestoscale-upHIV, treatment, eds. care and support Geneva World Health Organization.
2. World Health Organization (2011) Global AIDS Response. Epidemic Update and health sector progress towards Universal Access. Progress report. Geneva World Health Organization.
3. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R, (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19: 2141-2148.
4. Losina E, Bassett IV, Giddy J, Chetty S, Regan S, et al. (2010) The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS ONE 5: 9538.
5. Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, et al. (2009) Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr 51: 135-9.
6. Topp SM, Chipukuma JM, Chiko MM, Wamulume CS, Bolton-Moore C, et al. (2011) Opt-out provider-initiated HIV testing and counselling in primary care outpatient clinics in Zambia. Bull World Health Organ 89: 328-335.
7. Nsigaye R, Wringe A, Roura M, Kalluvya S, Urassa M, et al. (2009) From HIV diagnosis to treatment: evaluation of a referral system to promote and monitor access to antiretroviral therapyin rural Tanzania. J Int AIDS Soc 12: 31.
8. Nakigozi G, Makumbi F, Reynolds S, Galiwango R, Kagaayi J, et al. (2011) Non-enrollment for free community HIV care: findings from a population-based study in Rakai, Uganda. AIDS Care 23: 764-70.
9. Nsanzimana S, Ruton H, Lowrance DW, Cishahayo S, Nyemazi JP, et al. (2012) Cell Phone- and Internet-based Monitoring and Evaluation of the National Antiretroviral Treatment Program during Rapid Scale-up in Rwanda: TRACnet, 2004-2010. J Acquir Immune Defic Syndr 59: e17-23.
10. National Reference Laboratory, Rwanda Ministry of Health (2009) National standards and guidelines for testing and diagnosis of HIV/AIDS. Kigali Rwanda Ministry of Health.
11. TRAC Plus, Rwanda Ministry of Health (2009) Guidelines for the provision of comprehensive care to persons infected HIV in Rwanda. Kigali Rwanda Ministry of Health.
12. National TB Control Program, Rwanda Ministry of Health (2005) TB technical manual. Kigali Rwanda Ministry of Health.
13. Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, et al. (2010) Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS ONE 5: 13801.
14. Van Rompaey S, Kimfuta J, Kimbondo P, Monn C, Buve A, (2011) Operational assessment of access to ART in rural Africa: the example of Kisantu in Democratic Republic of the Congo. AIDS Care 23: 686-93.
15. Rosen S, Fox MP, (2011) Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 8: e1001056.
16. Larson BA, Brennan A, McNamara L, Long L, Rosen S, et al. (2010) Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bulletin of the World Health Organization 88: 675-680.
17. Fox MP, Rosen S, (2010) Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health 15: 1-15.
18. McGrath N, Glynn JR, Saul J, Kranzer K, Jahn A, et al. (2010) What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi. BMC Public Health 10: 601.
19. Lahuerta M, Lima J, Elul B, Okamura M, Alvim MF, et al. (2011) Patients enrolled in HIV care in Mozambique: Baseline characteristics and follow-up outcomes. J Acquir Immune Defic Syndr 58: 75-86.
20. Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, et al. (2009) Mortality and loss-to-follow-up during the pre-treatmen t period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 9: 290.
21. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, et al. (2009) Late disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub Saharan Africa. J Acquir Immune Defic Syndr. J Acquir Immune Defic Syndr 52: 280.
22. Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, et al. (2010) Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS 24: 2263-70.
23. Taylor-Smith K, Tweya H, Harries A, Schoutene E, Jahn A, (2010) Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi. Malawi Med J 22: 49-56.
24. Hawkins C, Chalamilla G, Okuma J, Spiegelman D, Hertzmark E, et al. (2011) Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting. AIDS 25: 1189-97.
25. Moore DM, Yiannoutsos CT, Musick BS, Tappero J, Degerman R, et al. (2011) Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr 58: 289-96.
26. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, et al. (2011) Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 155: 209-16.